Atlas Trials

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

Clinical trial NCT04675788 · COMPLETED

Trial details

NCT number
NCT04675788
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Long QT SyndromeAbnormalities, Drug-Induced
Start date
2021-09-02
Primary completion
2025-04-16
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.